Literature DB >> 2006911

The principal site of glycation of human complement factor B.

M A Niemann1, A S Bhown, E J Miller.   

Abstract

Accumulating amino acid sequence data have made it increasingly evident that many essential complement proteins have potentially modifiable lysine residues in putative critical functional regions. Evidence is now presented that glucose is covalently attached to lysine-266 of purified human complement Factor B as a result of glycation. Purified B was treated with NaB3H4, which reduces such bound glucose to a mixture of radiolabelled hexitols. Amino acid analysis revealed the expected radiolabelled hexitol-lysine epimers. In addition, fluorography of dried gels resolving the major high-molecular-mass h.p.l.c.-fractionated CNBr-cleavage peptides of NaB3H4-reduced B indicated that this radioactivity was specifically associated with the 15 kDa fragment derived from the N-terminal region of fragment Bb. Amino acid sequence analysis suggested that the C-terminal lysine (residue 266 of B) of the N-terminal Lys-Lys doublet of this peptide is preferentially modified. If such glycation can subsequently be shown to occur in vivo, then perhaps this modification might also be found to affect the functional activity of B and offer a potential explanation for some of the immunopathological complications of diseases exposing key plasma proteins, such as this active-site-containing proteinase of the multimeric alternative-complement-pathway C3/C5 convertases, to long-term high concentrations of glucose, such as the decreased resistance to infection and impaired chemotaxis and phagocytosis characteristic of diabetes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2006911      PMCID: PMC1150163          DOI: 10.1042/bj2740473

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

1.  Blood bactericidal studies and serum complement in diabetic patients.

Authors:  H H BALCH; M WATTERS
Journal:  J Surg Res       Date:  1963-06       Impact factor: 2.192

2.  Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins.

Authors:  C R Merril; D Goldman; S A Sedman; M H Ebert
Journal:  Science       Date:  1981-03-27       Impact factor: 47.728

3.  Characterization of glycosylated hemoglobins. Relevance to monitoring of diabetic control and analysis of other proteins.

Authors:  R L Garlick; J S Mazer; P J Higgins; H F Bunn
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

4.  Synthesis and quantitation of glucitollysine, a glycosylated amino acid elevated in proteins from diabetics.

Authors:  B Trüeb; G J Hughes; K H Winterhalter
Journal:  Anal Biochem       Date:  1982-01-15       Impact factor: 3.365

5.  Enhanced nonenzymatic glycosylation of blood proteins in stored blood.

Authors:  J G Szelényi; J Földi; S R Hollán
Journal:  Transfusion       Date:  1983 Jan-Feb       Impact factor: 3.157

6.  Ultrastructure of cobra venom factor-dependent C3/C5 convertase and its zymogen, factor B of human complement.

Authors:  C A Smith; C W Vogel; H J Müller-Eberhard
Journal:  J Biol Chem       Date:  1982-09-10       Impact factor: 5.157

7.  Characterization of the CNBr peptides generated from the factor B cleavage fragments, Ba and Bb, by molecular exclusion high performance liquid chromatography.

Authors:  M A Niemann; J E Mole
Journal:  Immunol Commun       Date:  1982

8.  Non-enzymatic glycosylation of tissue protein in diabetes in the rat.

Authors:  D K Yue; S McLennan; J R Turtle
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

9.  The principal site of nonenzymatic glycosylation of human serum albumin in vivo.

Authors:  R L Garlick; J S Mazer
Journal:  J Biol Chem       Date:  1983-05-25       Impact factor: 5.157

10.  Specific quantitation by HPLC of protein (lysine) bound glucose in human serum albumin and other glycosylated proteins.

Authors:  E Schleicher; O H Wieland
Journal:  J Clin Chem Clin Biochem       Date:  1981-02
View more
  5 in total

1.  Glycation of CD59 impairs complement regulation on erythrocytes from diabetic subjects.

Authors:  Catherine S Davies; Claire L Harris; B Paul Morgan
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

Review 2.  Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis.

Authors:  Robert A DeAngelis; Edimara S Reis; Daniel Ricklin; John D Lambris
Journal:  Immunobiology       Date:  2012-11       Impact factor: 3.144

Review 3.  Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus.

Authors:  Blanca I Restrepo; Larry S Schlesinger
Journal:  Tuberculosis (Edinb)       Date:  2013-12       Impact factor: 2.973

Review 4.  Mass spectrometric determination of early and advanced glycation in biology.

Authors:  Naila Rabbani; Amal Ashour; Paul J Thornalley
Journal:  Glycoconj J       Date:  2016-07-20       Impact factor: 2.916

5.  Associations of dicarbonyl stress with complement activation: the CODAM study.

Authors:  Ying Xin; Elisabeth Hertle; Carla J H van der Kallen; Casper G Schalkwijk; Coen D A Stehouwer; Marleen M J van Greevenbroek
Journal:  Diabetologia       Date:  2020-01-28       Impact factor: 10.122

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.